InvestorsHub Logo
Followers 3
Posts 336
Boards Moderated 0
Alias Born 02/02/2018

Re: derkampfer post# 1239

Sunday, 01/20/2019 10:21:03 PM

Sunday, January 20, 2019 10:21:03 PM

Post# of 1569
Zenosense, Inc. engages in developing medical devices. It includes the detection of the Methicillin-resistant Staphylococcus aureus. The firm uses Acute Myocardial Infarction, and MIDS Cardiac technologies. The company was founded on August 11, 2008 and is headquartered in Valencia, Spain.